Stocks and Investing
Stocks and Investing
Wed, November 5, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, November 4, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, November 3, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Randall Stanicky Upgraded (TEVA) to Buy and Increased Target to $68 on, Nov 3rd, 2014
Randall Stanicky of RBC Capital, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Buy and Increased Target from $57 to $68 on, Nov 3rd, 2014.
Randall has made no other calls on TEVA in the last 4 months.
There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, all agree with Randall's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Risinger of "Morgan Stanley" Maintained at Hold with Increased Target to $61 on, Friday, October 31st, 2014
- Chris Schott of "JP Morgan" Maintained at Hold with Increased Target to $58 on, Monday, July 28th, 2014